Search research articles
Contact Us
Filters
Showing results (11-20 of 104) with videos related to
Page
of 11
Sort By:
Journal of the American Society of Cytopathology
|
May 3, 2019
Increased cervical cancer risk associated with extended screening intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh Cervical Cancer Screening Model
R Marshall Austin, Agnieszka Onisko
Journal of the American Society of Cytopathology
|
May 3, 2019
Whose cervical screening model predictions will prove to be correct?
R Marshall Austin, Amanda Herbert
American Journal of Clinical Pathology
|
March 30, 2020
What Constitutes Optimal Cervical Screening for Young Women Ages 21 to 29 Years?
R Marshall Austin, Chenquan Zhao
Cancer Cytopathology
|
June 24, 2016
HPV test results provide useful risk stratification information in women with ASC-H Pap test findings
R Marshall Austin, Chengquan Zhao
Cytojournal
|
July 3, 2014
Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?
R Marshall Austin, Chengquan Zhao
Gynecologic Oncology
|
September 15, 2007
Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone
Chengquan Zhao, R Marshall Austin
Cancer
|
May 20, 2008
Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample
Chengquan Zhao, R Marshall Austin
Drug, Healthcare and Patient Safety
|
November 16, 2012
Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
Sonya Naryshkin, R Marshall Austin
Archives of Pathology & Laboratory Medicine
|
September 1, 2011
Unrecognized risks associated with new cervical screening guidelines for younger women
R Marshall Austin, Chengquan Zhao
American Journal of Clinical Pathology
|
April 29, 2016
Follow-up of Women With Negative Pap Test Results and Abnormal Clinical Signs or Symptoms
Rebecca Ocque, R Marshall Austin
Page
of 11
Search research articles
Search
Showing results (11-20 of 104) with videos related to
Sort By:
Page
of 11
Journal of the American Society of Cytopathology
|
May 3, 2019
Increased cervical cancer risk associated with extended screening intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh Cervical Cancer Screening Model
R Marshall Austin, Agnieszka Onisko
Journal of the American Society of Cytopathology
|
May 3, 2019
Whose cervical screening model predictions will prove to be correct?
R Marshall Austin, Amanda Herbert
American Journal of Clinical Pathology
|
March 30, 2020
What Constitutes Optimal Cervical Screening for Young Women Ages 21 to 29 Years?
R Marshall Austin, Chenquan Zhao
Cancer Cytopathology
|
June 24, 2016
HPV test results provide useful risk stratification information in women with ASC-H Pap test findings
R Marshall Austin, Chengquan Zhao
Cytojournal
|
July 3, 2014
Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?
R Marshall Austin, Chengquan Zhao
Gynecologic Oncology
|
September 15, 2007
Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone
Chengquan Zhao, R Marshall Austin
Cancer
|
May 20, 2008
Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample
Chengquan Zhao, R Marshall Austin
Drug, Healthcare and Patient Safety
|
November 16, 2012
Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
Sonya Naryshkin, R Marshall Austin
Archives of Pathology & Laboratory Medicine
|
September 1, 2011
Unrecognized risks associated with new cervical screening guidelines for younger women
R Marshall Austin, Chengquan Zhao
American Journal of Clinical Pathology
|
April 29, 2016
Follow-up of Women With Negative Pap Test Results and Abnormal Clinical Signs or Symptoms
Rebecca Ocque, R Marshall Austin
Page
of 11